Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for rCBV as an early response marker following bevacizumab treatment.

× No keyword cloud information.

3 in total

1. Predictive imaging marker of bevacizumab efficacy: perfusion MRI.

Authors: Whitney B Pope
Journal: Neuro Oncol Date: 2015-04-24 Impact factor: 12.300

2. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

Authors: Kathleen M Schmainda; Zheng Zhang; Melissa Prah; Bradley S Snyder; Mark R Gilbert; A Gregory Sorensen; Daniel P Barboriak; Jerrold L Boxerman
Journal: Neuro Oncol Date: 2015-02-02 Impact factor: 12.300

3. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.

Authors: Philipp Kickingereder; Benedikt Wiestler; Sina Burth; Antje Wick; Martha Nowosielski; Sabine Heiland; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch
Journal: Neuro Oncol Date: 2015-03-09 Impact factor: 12.300

3 in total

1 in total

1. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.

Authors: David Molina; Julián Pérez-Beteta; Alicia Martínez-González; Juan M Sepúlveda; Sergi Peralta; Miguel J Gil-Gil; Gaspar Reynes; Ana Herrero; Ramón De Las Peñas; Raquel Luque; Jaume Capellades; Carmen Balaña; Víctor M Pérez-García
Journal: PLoS One Date: 2016-08-24 Impact factor: 3.240

1 in total